Skip to main content
Erschienen in: Journal of Clinical Immunology 4/2010

01.07.2010

The Polymorphism of IL-17 G-152A was Associated with Childhood Asthma and Bacterial Colonization of the Hypopharynx in Bronchiolitis

verfasst von: Jiehua Chen, Yu Deng, Jing Zhao, Zhengxiu Luo, Wansheng Peng, Juan Yang, Luo Ren, Lijia Wang, Zhou Fu, Xiqiang Yang, Enmei Liu

Erschienen in: Journal of Clinical Immunology | Ausgabe 4/2010

Einloggen, um Zugang zu erhalten

Abstract

Objective

Interleukin (IL)-17 plays an important role in the pathogenesis of asthma. We investigated the association between single-nucleotide polymorphism (SNP) of IL-17 (rs2275913, IL-17 G-152A) and asthma-related traits. Its effect on IL-17 production was also attractive.

Methods

One hundred and sixty eight childhood asthmatic patients, 144 bronchiolitis patients, and 205 healthy controls were recruited in this study. SNP rs2275913 was genotyped by polymerase chain reaction–restriction fragment length polymorphism. Peripheral blood mononuclear cells (PBMCs) from parts of healthy controls with different genotype were isolated and cultured with phytohaemagglutinin (PHA) for detection of IL-17 in the supernatants.

Results

SNP rs2275913 was associated with asthma (P = 0.03) in genotype frequency test. Children with homozygous A were 2.29 times more likely to have asthma than others (95% confidence interval 1.39–3.78, P = 0.001). The strength of associations was moderately higher by allergy comorbidity. Furthermore, SNP rs2275913 A allele was associated with abnormal lung function and serum total IgE in asthmatics, although the production of IL-17 by PHA-induced PBMC seemed to be not different among individuals with different genotypes. The distribution of SNP rs2275913 in bronchiolitis was marginally statistically different with controls and demonstrated a tendency close to that in asthma. Higher Streptococcus pneumoniae and Moraxella catarrhalis detection rates were shown in bronchiolitis patients with homozygous A allele than those with other genotypes (20.8% vs. 3.7%, P < 0.01 and 20.8% vs. 6.2%, P = 0.03).

Conclusion

The preliminary results demonstrate that IL-17 SNP rs2275913 was associated with several asthma-related traits and confers genetic susceptibility to childhood asthma. It may be used to develop markers to assess the risk of asthma, especially in the bronchiolitis population. It may be a potential bridge to connect the bacterial colonization and the onset of asthma.
Literatur
2.
Zurück zum Zitat Umetsu DT, McIntire JJ, Akbari O, et al. Asthma: an epidemic of dysregulated immunity. Nat Immunol. 2002;3:715–20.CrossRefPubMed Umetsu DT, McIntire JJ, Akbari O, et al. Asthma: an epidemic of dysregulated immunity. Nat Immunol. 2002;3:715–20.CrossRefPubMed
3.
Zurück zum Zitat Douwes J, Gibson P, Pekkanen J, et al. Non-eosinophilic asthma: importance and possible mechanisms. Thorax. 2002;57:643–8.CrossRefPubMed Douwes J, Gibson P, Pekkanen J, et al. Non-eosinophilic asthma: importance and possible mechanisms. Thorax. 2002;57:643–8.CrossRefPubMed
4.
Zurück zum Zitat Luo Z, Xiao L, Liu E. The significance on the cell dynamic changes in the induced sputum in the different periods in children with asthma. J Clin Pediatr. 2005;23(09):615–7. in Chinese. Luo Z, Xiao L, Liu E. The significance on the cell dynamic changes in the induced sputum in the different periods in children with asthma. J Clin Pediatr. 2005;23(09):615–7. in Chinese.
5.
Zurück zum Zitat Schnyder-Candrian S, Togbe D, Couillin I, et al. Interleukin-17 is a negative regulator of established allergic asthma. J Exp Med. 2006;203(12):2715–25.CrossRefPubMed Schnyder-Candrian S, Togbe D, Couillin I, et al. Interleukin-17 is a negative regulator of established allergic asthma. J Exp Med. 2006;203(12):2715–25.CrossRefPubMed
7.
Zurück zum Zitat Bullens DM, Truyen E, Coteur L, et al. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir Res. 2006;7:135.CrossRefPubMed Bullens DM, Truyen E, Coteur L, et al. IL-17 mRNA in sputum of asthmatic patients: linking T cell driven inflammation and granulocytic influx? Respir Res. 2006;7:135.CrossRefPubMed
8.
Zurück zum Zitat Molet S, Hamid Q, Davoine F, et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol. 2001;108:430–8.CrossRefPubMed Molet S, Hamid Q, Davoine F, et al. IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines. J Allergy Clin Immunol. 2001;108:430–8.CrossRefPubMed
9.
Zurück zum Zitat Chakir J, Shannon J, Molet S, et al. Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-β, IL-11, IL-17, and type I and type III collagen expression. J Allergy Clin Immunol. 2003;111:1293–8.CrossRefPubMed Chakir J, Shannon J, Molet S, et al. Airway remodeling-associated mediators in moderate to severe asthma: effect of steroids on TGF-β, IL-11, IL-17, and type I and type III collagen expression. J Allergy Clin Immunol. 2003;111:1293–8.CrossRefPubMed
10.
Zurück zum Zitat Sun YC, Zhou QT, Yao WZ. Sputum interleukin-17 is increased and associated with airway neutrophilia in patients with severe asthma. Chin Med J. 2005;118:953–6.PubMed Sun YC, Zhou QT, Yao WZ. Sputum interleukin-17 is increased and associated with airway neutrophilia in patients with severe asthma. Chin Med J. 2005;118:953–6.PubMed
11.
Zurück zum Zitat Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu Rev Immunol. 2009;27:485–517.CrossRefPubMed Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu Rev Immunol. 2009;27:485–517.CrossRefPubMed
12.
Zurück zum Zitat Arisawa T, Tahara T, Shibata T, et al. The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis. J Clin Immunol. 2008;28(1):44–9.CrossRefPubMed Arisawa T, Tahara T, Shibata T, et al. The influence of polymorphisms of interleukin-17A and interleukin-17F genes on the susceptibility to ulcerative colitis. J Clin Immunol. 2008;28(1):44–9.CrossRefPubMed
13.
Zurück zum Zitat Nordang GB, Viken MK, Hollis-Moffatt JE, et al. Association analysis of the interleukin 17A gene in Caucasian rheumatoid arthritis patients from Norway and New Zealand. Rheumatology. 2009;48(4):367–70.CrossRefPubMed Nordang GB, Viken MK, Hollis-Moffatt JE, et al. Association analysis of the interleukin 17A gene in Caucasian rheumatoid arthritis patients from Norway and New Zealand. Rheumatology. 2009;48(4):367–70.CrossRefPubMed
14.
Zurück zum Zitat Koppelman GH, te Meerman GJ, Postma DS. Genetic testing for asthma. Eur Respir J. 2008;32(3):775–82.CrossRefPubMed Koppelman GH, te Meerman GJ, Postma DS. Genetic testing for asthma. Eur Respir J. 2008;32(3):775–82.CrossRefPubMed
15.
Zurück zum Zitat Wjst M, Fischer G, Immervoll T, et al. A genome-wide search for linkage to asthma. German Asthma Genetics Group. Genomics. 1999;58:1–8.CrossRefPubMed Wjst M, Fischer G, Immervoll T, et al. A genome-wide search for linkage to asthma. German Asthma Genetics Group. Genomics. 1999;58:1–8.CrossRefPubMed
16.
Zurück zum Zitat Haagerup A, Bjerke T, Schiotz PO, et al. Asthma and atopy—a total genome scan for susceptibility genes. Allergy. 2002;57:680–6.CrossRefPubMed Haagerup A, Bjerke T, Schiotz PO, et al. Asthma and atopy—a total genome scan for susceptibility genes. Allergy. 2002;57:680–6.CrossRefPubMed
17.
Zurück zum Zitat Wang JY, Lin CGJ, Bey MSJ, et al. Discovery of genetic difference between asthmatic children with high IgE level and normal IgE level by whole genome linkage disequilibrium mapping using 763 autosomal STR markers. J Hum Genet. 2005;50:249–58.CrossRefPubMed Wang JY, Lin CGJ, Bey MSJ, et al. Discovery of genetic difference between asthmatic children with high IgE level and normal IgE level by whole genome linkage disequilibrium mapping using 763 autosomal STR markers. J Hum Genet. 2005;50:249–58.CrossRefPubMed
18.
Zurück zum Zitat Singh AM, Moore PE, Gern JE, et al. Bronchiolitis to asthma: a review and call for studies of gene–virus interactions in asthma causation. Am J Respir Crit Care Med. 2007;175(2):108–19.CrossRefPubMed Singh AM, Moore PE, Gern JE, et al. Bronchiolitis to asthma: a review and call for studies of gene–virus interactions in asthma causation. Am J Respir Crit Care Med. 2007;175(2):108–19.CrossRefPubMed
19.
Zurück zum Zitat Polonikov AV, Ivanov VP, Solodilova MA, et al. Promoter polymorphism G-50T of a human CYP2J2 epoxygenase gene is associated with common susceptibility to asthma. Chest. 2007;132(1):120–6.CrossRefPubMed Polonikov AV, Ivanov VP, Solodilova MA, et al. Promoter polymorphism G-50T of a human CYP2J2 epoxygenase gene is associated with common susceptibility to asthma. Chest. 2007;132(1):120–6.CrossRefPubMed
20.
Zurück zum Zitat Sub-Committee on Skin Tests of the European Academy of Allergology and Clinical Immunology. Skin tests used in type I allergy testing Position paper. Allergy. 1989;44 Suppl 10:1–59. Sub-Committee on Skin Tests of the European Academy of Allergology and Clinical Immunology. Skin tests used in type I allergy testing Position paper. Allergy. 1989;44 Suppl 10:1–59.
21.
Zurück zum Zitat Isidoro-García M, Dávila I, Laffond E, et al. Interleukin-4 (IL4) and interleukin-4 receptor (IL4RA) polymorphisms in asthma: a case control study. Clin Mol Allergy. 2005;3:15.CrossRefPubMed Isidoro-García M, Dávila I, Laffond E, et al. Interleukin-4 (IL4) and interleukin-4 receptor (IL4RA) polymorphisms in asthma: a case control study. Clin Mol Allergy. 2005;3:15.CrossRefPubMed
22.
Zurück zum Zitat El-Radhi AS, Barry W, Patel S. Association of fever and severe clinical course in bronchiolitis. Arch Dis Child. 1999;81(3):231–4.CrossRefPubMed El-Radhi AS, Barry W, Patel S. Association of fever and severe clinical course in bronchiolitis. Arch Dis Child. 1999;81(3):231–4.CrossRefPubMed
23.
Zurück zum Zitat Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005;15(2):97–8.CrossRefPubMed Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005;15(2):97–8.CrossRefPubMed
24.
Zurück zum Zitat Bisgaard H, Hermansen MN, Buchvald F, et al. Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med. 2007;357(15):1487–95.CrossRefPubMed Bisgaard H, Hermansen MN, Buchvald F, et al. Childhood asthma after bacterial colonization of the airway in neonates. N Engl J Med. 2007;357(15):1487–95.CrossRefPubMed
25.
Zurück zum Zitat Barczyk A, Pierzchala W, Sozañska E. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir Med. 2003;97(6):726–33.CrossRefPubMed Barczyk A, Pierzchala W, Sozañska E. Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine. Respir Med. 2003;97(6):726–33.CrossRefPubMed
26.
Zurück zum Zitat Furuya T, Hakoda M, Ichikawa N, Higami K, Nanke Y, et al. Associations between HLA-DRB1, RANK, RANKL, OPG, and IL-17 genotypes and disease severity phenotypes in Japanese patients with early rheumatoid arthritis. Clin Rheumatol. 2007;26(12):2137–41.CrossRefPubMed Furuya T, Hakoda M, Ichikawa N, Higami K, Nanke Y, et al. Associations between HLA-DRB1, RANK, RANKL, OPG, and IL-17 genotypes and disease severity phenotypes in Japanese patients with early rheumatoid arthritis. Clin Rheumatol. 2007;26(12):2137–41.CrossRefPubMed
27.
Zurück zum Zitat Lindén A. Rationale for targeting interleukin-17 in the lungs. Curr Opin Investig Drugs. 2003;4(11):1304–12.PubMed Lindén A. Rationale for targeting interleukin-17 in the lungs. Curr Opin Investig Drugs. 2003;4(11):1304–12.PubMed
28.
Zurück zum Zitat Sherrill DL, Lebowitz MD, Halonen M, Barbee RA, Burrows B. Longitudinal evaluation of the association between pulmonary function and total serum IgE. Am J Respir Crit Care Med. 1995;152:98–102.PubMed Sherrill DL, Lebowitz MD, Halonen M, Barbee RA, Burrows B. Longitudinal evaluation of the association between pulmonary function and total serum IgE. Am J Respir Crit Care Med. 1995;152:98–102.PubMed
29.
Zurück zum Zitat Hashimoto T, Akiyama K, Kobayashi N, et al. Comparison of IL-17 production by helper T cells among atopic and nonatopic asthmatics and control subjects. Int Arch Allergy Immunol. 2005;137 suppl 1:51–4.CrossRefPubMed Hashimoto T, Akiyama K, Kobayashi N, et al. Comparison of IL-17 production by helper T cells among atopic and nonatopic asthmatics and control subjects. Int Arch Allergy Immunol. 2005;137 suppl 1:51–4.CrossRefPubMed
30.
Zurück zum Zitat Wang JY, Shyur SD, Wang WH, et al. The polymorphisms of interleukin 17A (IL17A) gene and its association with pediatric asthma in Taiwanese population. Allergy. 2009;64(7):1056–60.CrossRefPubMed Wang JY, Shyur SD, Wang WH, et al. The polymorphisms of interleukin 17A (IL17A) gene and its association with pediatric asthma in Taiwanese population. Allergy. 2009;64(7):1056–60.CrossRefPubMed
31.
Zurück zum Zitat Shuhua Xu, Xianyong Yin, Shilin Li, et al. Genomic dissection of population substructure of Han Chinese and its implication in association studies. Am J Hum Genet. 2009;85(6):762–74.CrossRef Shuhua Xu, Xianyong Yin, Shilin Li, et al. Genomic dissection of population substructure of Han Chinese and its implication in association studies. Am J Hum Genet. 2009;85(6):762–74.CrossRef
32.
Zurück zum Zitat Kalina WV, Gershwin LJ. Progress in defining the role of RSV in allergy and asthma: from clinical observations to animal models. Clin Dev Immunol. 2004;11(2):113–9.CrossRefPubMed Kalina WV, Gershwin LJ. Progress in defining the role of RSV in allergy and asthma: from clinical observations to animal models. Clin Dev Immunol. 2004;11(2):113–9.CrossRefPubMed
33.
Zurück zum Zitat Bettelli, Korn T, Oukka M, et al. Induction and effector functions of T(H)17 cells. Nature. 2008;453(7198):1051–7.CrossRefPubMed Bettelli, Korn T, Oukka M, et al. Induction and effector functions of T(H)17 cells. Nature. 2008;453(7198):1051–7.CrossRefPubMed
34.
Zurück zum Zitat Lu YJ, Gross J, Bogaert D, et al. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog. 2008;4(9):e1000159.CrossRefPubMed Lu YJ, Gross J, Bogaert D, et al. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog. 2008;4(9):e1000159.CrossRefPubMed
Metadaten
Titel
The Polymorphism of IL-17 G-152A was Associated with Childhood Asthma and Bacterial Colonization of the Hypopharynx in Bronchiolitis
verfasst von
Jiehua Chen
Yu Deng
Jing Zhao
Zhengxiu Luo
Wansheng Peng
Juan Yang
Luo Ren
Lijia Wang
Zhou Fu
Xiqiang Yang
Enmei Liu
Publikationsdatum
01.07.2010
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 4/2010
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-010-9391-8

Weitere Artikel der Ausgabe 4/2010

Journal of Clinical Immunology 4/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

CAR-M-Zellen: Warten auf das große Fressen

22.05.2024 Onkologische Immuntherapie Nachrichten

Auch myeloide Immunzellen lassen sich mit chimären Antigenrezeptoren gegen Tumoren ausstatten. Solche CAR-Fresszell-Therapien werden jetzt für solide Tumoren entwickelt. Künftig soll dieser Prozess nicht mehr ex vivo, sondern per mRNA im Körper der Betroffenen erfolgen.

Frühzeitige HbA1c-Kontrolle macht sich lebenslang bemerkbar

22.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes von Anfang an intensiv BZ-senkend zu behandeln, wirkt sich positiv auf Komplikationen und Mortalität aus – und das offenbar lebenslang, wie eine weitere Nachfolgeuntersuchung der UKPD-Studie nahelegt.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.